Epigral reported audited standalone Q4 FY26 revenue of ₹736.16 crore and net profit of ₹81.93 crore, with full-year profit at ₹333.01 crore.
Board recommended a final dividend of ₹5.00 (50%) per equity share of face value ₹10 for FY 2025-26.
Auditors issued an unmodified opinion on both standalone and consolidated financial results for the quarter and year ended March 31, 2026.
Company invested in a 19.80 MW wind-solar hybrid power project through Pro-Zeal Green Power Ten Private Limited.